Teva Pharmaceutical Industries Ltd.

Pharmaceuticals
Israel
Executive 1Mr. Erez Vigodman, President; Chief Executive Officer | President; Chief Executive Officer
Executive 2Iris Beck-Codner, Executive Vice President; | Executive Vice President;
Earnings Per Share Growth (%)138.93%
Cost of Goods Sold (US$ Millions)$9,216
Current Liabilities (US$ Millions)$12,289
Total Assets (US$ Millions)$14,396
Long Term Debt (Millions)$8,566
Return on Equity13.54%
Revenue (US$ Millions)$20,272
Total Company Assets$46,420
Revenue Growth (%)-0.21%
Net Income (US$ Millions)$3,055
Earnings Per Share (US$)$3.56
Total Equity (US$ Millions)$23,313
Profit Margin (%)15.07%
Debt To Equity Ratio (%)0.37%
Inventories (Millions)$4,371